BWXT agrees to sell medical business to Nordic Capital in deal valued up to $800 million - BWXT News | RalliesBWXT agrees to sell medical business to Nordic Capital in deal valued up to $800 million
B
BWXT• BWXT to sell medical business to Nordic Capital
- BWX Technologies agreed to sell its medical business to Nordic Capital in a transaction valued at up to $800 million.
- The deal includes BWXT Medical and Kinectrics’ stable medical isotopes business.
- BWXT will retain a minority stake and continue providing isotope and radiochemical expertise under the agreement.
- Proceeds will shift resources toward BWXT’s nuclear national security and commercial nuclear power markets.
- Closing is expected by the end of 2026, subject to customary regulatory approvals.
•
